Insider Trading History of Lawlor Augustine


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lawlor Augustine since year 2005. The trader's CIK number is 1262327. At the time of the last reporting, Lawlor Augustine was the Director of Leap Therapeutics, Inc. . (stock ticker symbol LPTX). See this page for all insider trading activities at Leap Therapeutics, Inc. .

Note that in the past LAWLOR AUGUSTINE also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lawlor Augustine since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-02-05 LPTX Leap Therapeutics, Inc. Buy 571,428 1.75 999,999
2017-11-14 LPTX Leap Therapeutics, Inc. Buy 1,057,769 6.08 6,436,524
2016-03-18 GBIM Globeimmune Inc Sale 11,000 1.55 17,050
2016-03-15 GBIM Globeimmune Inc Sale 2,500 2.05 5,125
2016-03-10 GBIM Globeimmune Inc Sale 200 1.35 270
2016-03-11 GBIM Globeimmune Inc Sale 16,300 1.60 26,080
2016-03-04 GBIM Globeimmune Inc Sale 5,000 1.05 5,250
2016-03-07 GBIM Globeimmune Inc Sale 5,010 .99 4,959
2016-03-08 GBIM Globeimmune Inc Sale 5,000 1.10 5,500
2014-08-21 CSII Cardiovascular Systems Inc Sale 361,235 28.05 10,132,641

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lawlor Augustine (Director of Leap Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.